Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size was valued at US$ 4983 million in 2025 and is forecast to a readjusted size of US$ 18278 million by 2032 with a CAGR of 20.4% during review period.
Non-steroidal androgen receptor inhibitors (NSARIs) are a class of oral small-molecule drugs that competitively bind to the androgen receptor (AR), inhibiting its nuclear translocation and transcriptional activity without possessing a steroidal structure; they selectively block androgen signaling pathways that drive prostate cancer progression and represent a core component of endocrine therapy for prostate cancer; the class has evolved from first-generation agents (e.g., bicalutamide) to second-generation high-affinity inhibitors such as Enzalutamide, Apalutamide, and Darolutamide, with continuous improvements in efficacy, resistance management, and safety profile, primarily indicated for nmCRPC and mHSPC and typically used in combination with androgen deprivation therapy (ADT).The global market for non-steroidal androgen receptor inhibitors is estimated at USD 4.8 billion in 2025, with a projected CAGR of approximately 20.85% from 2025 to 2030, corresponding to an annual treated patient population of about 500,000–600,000, driven by increasing penetration in nmCRPC, mCRPC, and mHSPC. Nominal capacity from the global high-potency small-molecule API network is sufficient to meet demand, and capacity does not constitute a constraint. Average treatment cost per patient per year is approximately USD 90,000–100,000 in the U.S., USD 50,000–70,000 in Europe, and USD 15,000–20,000 in China post-reimbursement negotiations, resulting in a weighted average of about USD 65,000 per patient per year, with a blended gross margin of roughly 85–90%.
Downstream demand is concentrated in the prostate cancer treatment pathway within oncology (nmCRPC ? mCRPC ? mHSPC). The value chain upstream consists of high-potency APIs and key intermediates synthesized via multi-step heterocyclic processes; midstream commercialization is led by originator companies (Astellas Pharma Inc., Pfizer Inc., Johnson & Johnson, and Bayer AG/Orion Corporation); downstream channels consist of hospitals and oncology specialty clinics. The global industry structure is characterized by “originator oligopoly + guideline-driven adoption + patent protection,” with primary competition from Enzalutamide, Apalutamide, and Darolutamide. The core compound patent of Darolutamide is expected to expire around 2030, but indication, formulation, and regional patent extensions may prolong actual market exclusivity to 2032–2035. Overall, the market is in the late growth stage, driven primarily by indication expansion and an increasing aging patient population, with key uncertainty arising from post-patent generic entry and reimbursement pressure.
This report is a detailed and comprehensive analysis for global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-steroidal Androgen Receptor Inhibitors?NSARIs? market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-steroidal Androgen Receptor Inhibitors?NSARIs? product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-steroidal Androgen Receptor Inhibitors?NSARIs?, with price, sales quantity, revenue, and global market share of Non-steroidal Androgen Receptor Inhibitors?NSARIs? from 2021 to 2026.
Chapter 3, the Non-steroidal Androgen Receptor Inhibitors?NSARIs? competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-steroidal Androgen Receptor Inhibitors?NSARIs? breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-steroidal Androgen Receptor Inhibitors?NSARIs? market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-steroidal Androgen Receptor Inhibitors?NSARIs?.
Chapter 14 and 15, to describe Non-steroidal Androgen Receptor Inhibitors?NSARIs? sales channel, distributors, customers, research findings and conclusion.
Non-steroidal androgen receptor inhibitors (NSARIs) are a class of oral small-molecule drugs that competitively bind to the androgen receptor (AR), inhibiting its nuclear translocation and transcriptional activity without possessing a steroidal structure; they selectively block androgen signaling pathways that drive prostate cancer progression and represent a core component of endocrine therapy for prostate cancer; the class has evolved from first-generation agents (e.g., bicalutamide) to second-generation high-affinity inhibitors such as Enzalutamide, Apalutamide, and Darolutamide, with continuous improvements in efficacy, resistance management, and safety profile, primarily indicated for nmCRPC and mHSPC and typically used in combination with androgen deprivation therapy (ADT).The global market for non-steroidal androgen receptor inhibitors is estimated at USD 4.8 billion in 2025, with a projected CAGR of approximately 20.85% from 2025 to 2030, corresponding to an annual treated patient population of about 500,000–600,000, driven by increasing penetration in nmCRPC, mCRPC, and mHSPC. Nominal capacity from the global high-potency small-molecule API network is sufficient to meet demand, and capacity does not constitute a constraint. Average treatment cost per patient per year is approximately USD 90,000–100,000 in the U.S., USD 50,000–70,000 in Europe, and USD 15,000–20,000 in China post-reimbursement negotiations, resulting in a weighted average of about USD 65,000 per patient per year, with a blended gross margin of roughly 85–90%.
Downstream demand is concentrated in the prostate cancer treatment pathway within oncology (nmCRPC ? mCRPC ? mHSPC). The value chain upstream consists of high-potency APIs and key intermediates synthesized via multi-step heterocyclic processes; midstream commercialization is led by originator companies (Astellas Pharma Inc., Pfizer Inc., Johnson & Johnson, and Bayer AG/Orion Corporation); downstream channels consist of hospitals and oncology specialty clinics. The global industry structure is characterized by “originator oligopoly + guideline-driven adoption + patent protection,” with primary competition from Enzalutamide, Apalutamide, and Darolutamide. The core compound patent of Darolutamide is expected to expire around 2030, but indication, formulation, and regional patent extensions may prolong actual market exclusivity to 2032–2035. Overall, the market is in the late growth stage, driven primarily by indication expansion and an increasing aging patient population, with key uncertainty arising from post-patent generic entry and reimbursement pressure.
This report is a detailed and comprehensive analysis for global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Non-steroidal Androgen Receptor Inhibitors?NSARIs?
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-steroidal Androgen Receptor Inhibitors?NSARIs? market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Enzalutamide
- Apalutamide
- Darolutamide
- Bicalutamide
- Nilutamide
- High BBB Penetration
- Low BBB Penetration
- nmCRPC
- mCRPC
- mHSPC
- Others
- Astellas Pharma
- Pfizer
- Johnson & Johnson
- Bayer AG
- Orion
- Lonza Group
- Catalent
- WuXi AppTec
- Asymchem Laboratories
- Recipharm
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Non-steroidal Androgen Receptor Inhibitors?NSARIs? product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-steroidal Androgen Receptor Inhibitors?NSARIs?, with price, sales quantity, revenue, and global market share of Non-steroidal Androgen Receptor Inhibitors?NSARIs? from 2021 to 2026.
Chapter 3, the Non-steroidal Androgen Receptor Inhibitors?NSARIs? competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-steroidal Androgen Receptor Inhibitors?NSARIs? breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-steroidal Androgen Receptor Inhibitors?NSARIs? market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-steroidal Androgen Receptor Inhibitors?NSARIs?.
Chapter 14 and 15, to describe Non-steroidal Androgen Receptor Inhibitors?NSARIs? sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Enzalutamide
1.3.3 Apalutamide
1.3.4 Darolutamide
1.3.5 Bicalutamide
1.3.6 Nilutamide
1.4 Market Analysis by Molecular
1.4.1 Overview: Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Molecular: 2021 Versus 2025 Versus 2032
1.4.2 High BBB Penetration
1.4.3 Low BBB Penetration
1.5 Market Analysis by Application
1.5.1 Overview: Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 nmCRPC
1.5.3 mCRPC
1.5.4 mHSPC
1.5.5 Others
1.6 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size & Forecast
1.6.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (2021-2032)
1.6.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.1.4 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Astellas Pharma Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.2.4 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Pfizer Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.3.4 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.4.4 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Orion
2.5.1 Orion Details
2.5.2 Orion Major Business
2.5.3 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.5.4 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Orion Recent Developments/Updates
2.6 Lonza Group
2.6.1 Lonza Group Details
2.6.2 Lonza Group Major Business
2.6.3 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.6.4 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Lonza Group Recent Developments/Updates
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.7.4 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Catalent Recent Developments/Updates
2.8 WuXi AppTec
2.8.1 WuXi AppTec Details
2.8.2 WuXi AppTec Major Business
2.8.3 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.8.4 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 WuXi AppTec Recent Developments/Updates
2.9 Asymchem Laboratories
2.9.1 Asymchem Laboratories Details
2.9.2 Asymchem Laboratories Major Business
2.9.3 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.9.4 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Asymchem Laboratories Recent Developments/Updates
2.10 Recipharm
2.10.1 Recipharm Details
2.10.2 Recipharm Major Business
2.10.3 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.10.4 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Recipharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-STEROIDAL ANDROGEN RECEPTOR INHIBITORS?NSARIS? BY MANUFACTURER
3.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Manufacturer (2021-2026)
3.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Manufacturer (2021-2026)
3.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Non-steroidal Androgen Receptor Inhibitors?NSARIs? by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer Market Share in 2025
3.4.3 Top 6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer Market Share in 2025
3.5 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Overall Company Footprint Analysis
3.5.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Region Footprint
3.5.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
3.5.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Region
4.1.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2032)
4.1.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2032)
4.1.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2032)
4.2 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.3 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.4 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.5 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.6 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
5.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type (2021-2032)
5.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
6.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application (2021-2032)
6.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
7.2 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
7.3 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
7.3.1 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
7.3.2 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
8.2 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
8.3 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
8.3.1 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
8.3.2 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
10.2 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
10.3 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
10.3.1 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
10.3.2 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
12.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Restraints
12.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-steroidal Androgen Receptor Inhibitors?NSARIs? and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-steroidal Androgen Receptor Inhibitors?NSARIs?
13.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
14.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Enzalutamide
1.3.3 Apalutamide
1.3.4 Darolutamide
1.3.5 Bicalutamide
1.3.6 Nilutamide
1.4 Market Analysis by Molecular
1.4.1 Overview: Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Molecular: 2021 Versus 2025 Versus 2032
1.4.2 High BBB Penetration
1.4.3 Low BBB Penetration
1.5 Market Analysis by Application
1.5.1 Overview: Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 nmCRPC
1.5.3 mCRPC
1.5.4 mHSPC
1.5.5 Others
1.6 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size & Forecast
1.6.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (2021-2032)
1.6.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.1.4 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Astellas Pharma Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.2.4 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Pfizer Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.3.4 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.4.4 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Orion
2.5.1 Orion Details
2.5.2 Orion Major Business
2.5.3 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.5.4 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Orion Recent Developments/Updates
2.6 Lonza Group
2.6.1 Lonza Group Details
2.6.2 Lonza Group Major Business
2.6.3 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.6.4 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Lonza Group Recent Developments/Updates
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.7.4 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Catalent Recent Developments/Updates
2.8 WuXi AppTec
2.8.1 WuXi AppTec Details
2.8.2 WuXi AppTec Major Business
2.8.3 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.8.4 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 WuXi AppTec Recent Developments/Updates
2.9 Asymchem Laboratories
2.9.1 Asymchem Laboratories Details
2.9.2 Asymchem Laboratories Major Business
2.9.3 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.9.4 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Asymchem Laboratories Recent Developments/Updates
2.10 Recipharm
2.10.1 Recipharm Details
2.10.2 Recipharm Major Business
2.10.3 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
2.10.4 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Recipharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-STEROIDAL ANDROGEN RECEPTOR INHIBITORS?NSARIS? BY MANUFACTURER
3.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Manufacturer (2021-2026)
3.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Manufacturer (2021-2026)
3.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Non-steroidal Androgen Receptor Inhibitors?NSARIs? by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer Market Share in 2025
3.4.3 Top 6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer Market Share in 2025
3.5 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Overall Company Footprint Analysis
3.5.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Region Footprint
3.5.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
3.5.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Region
4.1.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2032)
4.1.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2032)
4.1.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2032)
4.2 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.3 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.4 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.5 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
4.6 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
5.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type (2021-2032)
5.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
6.2 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application (2021-2032)
6.3 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
7.2 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
7.3 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
7.3.1 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
7.3.2 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
8.2 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
8.3 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
8.3.1 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
8.3.2 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
10.2 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
10.3 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
10.3.1 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
10.3.2 South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
12.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Restraints
12.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-steroidal Androgen Receptor Inhibitors?NSARIs? and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-steroidal Androgen Receptor Inhibitors?NSARIs?
13.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
14.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Molecular, (USD Million), 2021 & 2025 & 2032
Table 3. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 5. Astellas Pharma Major Business
Table 6. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 7. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Astellas Pharma Recent Developments/Updates
Table 9. Pfizer Basic Information, Manufacturing Base and Competitors
Table 10. Pfizer Major Business
Table 11. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 12. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Pfizer Recent Developments/Updates
Table 14. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 17. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Johnson & Johnson Recent Developments/Updates
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 22. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bayer AG Recent Developments/Updates
Table 24. Orion Basic Information, Manufacturing Base and Competitors
Table 25. Orion Major Business
Table 26. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 27. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Orion Recent Developments/Updates
Table 29. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 30. Lonza Group Major Business
Table 31. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 32. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Lonza Group Recent Developments/Updates
Table 34. Catalent Basic Information, Manufacturing Base and Competitors
Table 35. Catalent Major Business
Table 36. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 37. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Catalent Recent Developments/Updates
Table 39. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 40. WuXi AppTec Major Business
Table 41. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 42. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. WuXi AppTec Recent Developments/Updates
Table 44. Asymchem Laboratories Basic Information, Manufacturing Base and Competitors
Table 45. Asymchem Laboratories Major Business
Table 46. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 47. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Asymchem Laboratories Recent Developments/Updates
Table 49. Recipharm Basic Information, Manufacturing Base and Competitors
Table 50. Recipharm Major Business
Table 51. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 52. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Recipharm Recent Developments/Updates
Table 54. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 55. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Manufacturer (2021-2026) & (USD Million)
Table 56. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 57. Market Position of Manufacturers in Non-steroidal Androgen Receptor Inhibitors?NSARIs?, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 58. Head Office and Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Site of Key Manufacturer
Table 59. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
Table 60. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
Table 61. Non-steroidal Androgen Receptor Inhibitors?NSARIs? New Market Entrants and Barriers to Market Entry
Table 62. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 64. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2026) & (Tons)
Table 65. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2027-2032) & (Tons)
Table 66. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2026) & (USD Million)
Table 67. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2027-2032) & (USD Million)
Table 68. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2026) & (US$/Ton)
Table 69. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2027-2032) & (US$/Ton)
Table 70. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 71. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 72. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type (2021-2026) & (USD Million)
Table 73. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type (2027-2032) & (USD Million)
Table 74. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2026) & (US$/Ton)
Table 75. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2027-2032) & (US$/Ton)
Table 76. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 77. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 78. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application (2021-2026) & (USD Million)
Table 79. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application (2027-2032) & (USD Million)
Table 80. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2026) & (US$/Ton)
Table 81. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2027-2032) & (US$/Ton)
Table 82. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 83. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 84. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 85. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 86. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 87. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 88. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 89. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 91. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 92. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 93. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 94. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 95. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 96. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 97. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 99. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 100. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 101. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 102. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2026) & (Tons)
Table 103. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2027-2032) & (Tons)
Table 104. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2026) & (USD Million)
Table 105. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2027-2032) & (USD Million)
Table 106. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 107. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 108. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 109. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 110. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 111. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 112. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 115. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 116. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 117. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 118. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 119. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 120. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Raw Material
Table 123. Key Manufacturers of Non-steroidal Androgen Receptor Inhibitors?NSARIs? Raw Materials
Table 124. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
Table 125. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Customers
Table 1. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Molecular, (USD Million), 2021 & 2025 & 2032
Table 3. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 5. Astellas Pharma Major Business
Table 6. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 7. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Astellas Pharma Recent Developments/Updates
Table 9. Pfizer Basic Information, Manufacturing Base and Competitors
Table 10. Pfizer Major Business
Table 11. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 12. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Pfizer Recent Developments/Updates
Table 14. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 17. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Johnson & Johnson Recent Developments/Updates
Table 19. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 20. Bayer AG Major Business
Table 21. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 22. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bayer AG Recent Developments/Updates
Table 24. Orion Basic Information, Manufacturing Base and Competitors
Table 25. Orion Major Business
Table 26. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 27. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Orion Recent Developments/Updates
Table 29. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 30. Lonza Group Major Business
Table 31. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 32. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Lonza Group Recent Developments/Updates
Table 34. Catalent Basic Information, Manufacturing Base and Competitors
Table 35. Catalent Major Business
Table 36. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 37. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Catalent Recent Developments/Updates
Table 39. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 40. WuXi AppTec Major Business
Table 41. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 42. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. WuXi AppTec Recent Developments/Updates
Table 44. Asymchem Laboratories Basic Information, Manufacturing Base and Competitors
Table 45. Asymchem Laboratories Major Business
Table 46. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 47. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Asymchem Laboratories Recent Developments/Updates
Table 49. Recipharm Basic Information, Manufacturing Base and Competitors
Table 50. Recipharm Major Business
Table 51. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 52. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Recipharm Recent Developments/Updates
Table 54. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 55. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Manufacturer (2021-2026) & (USD Million)
Table 56. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 57. Market Position of Manufacturers in Non-steroidal Androgen Receptor Inhibitors?NSARIs?, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 58. Head Office and Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Site of Key Manufacturer
Table 59. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
Table 60. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
Table 61. Non-steroidal Androgen Receptor Inhibitors?NSARIs? New Market Entrants and Barriers to Market Entry
Table 62. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 64. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2026) & (Tons)
Table 65. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2027-2032) & (Tons)
Table 66. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2026) & (USD Million)
Table 67. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2027-2032) & (USD Million)
Table 68. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2026) & (US$/Ton)
Table 69. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2027-2032) & (US$/Ton)
Table 70. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 71. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 72. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type (2021-2026) & (USD Million)
Table 73. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Type (2027-2032) & (USD Million)
Table 74. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2026) & (US$/Ton)
Table 75. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2027-2032) & (US$/Ton)
Table 76. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 77. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 78. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application (2021-2026) & (USD Million)
Table 79. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application (2027-2032) & (USD Million)
Table 80. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2026) & (US$/Ton)
Table 81. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2027-2032) & (US$/Ton)
Table 82. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 83. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 84. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 85. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 86. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 87. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 88. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 89. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 90. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 91. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 92. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 93. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 94. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 95. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 96. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 97. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 99. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 100. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 101. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 102. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2021-2026) & (Tons)
Table 103. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Region (2027-2032) & (Tons)
Table 104. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2021-2026) & (USD Million)
Table 105. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Region (2027-2032) & (USD Million)
Table 106. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 107. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 108. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 109. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 110. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 111. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 112. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2021-2026) & (Tons)
Table 115. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Type (2027-2032) & (Tons)
Table 116. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2021-2026) & (Tons)
Table 117. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Application (2027-2032) & (Tons)
Table 118. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2021-2026) & (Tons)
Table 119. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity by Country (2027-2032) & (Tons)
Table 120. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Raw Material
Table 123. Key Manufacturers of Non-steroidal Androgen Receptor Inhibitors?NSARIs? Raw Materials
Table 124. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
Table 125. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Customers
LIST OF FIGURES
Figure 1. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Picture
Figure 2. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Type in 2025
Figure 4. Enzalutamide Examples
Figure 5. Apalutamide Examples
Figure 6. Darolutamide Examples
Figure 7. Bicalutamide Examples
Figure 8. Nilutamide Examples
Figure 9. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Molecular, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Molecular in 2025
Figure 11. High BBB Penetration Examples
Figure 12. Low BBB Penetration Examples
Figure 13. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Application in 2025
Figure 15. nmCRPC Examples
Figure 16. mCRPC Examples
Figure 17. mHSPC Examples
Figure 18. Others Examples
Figure 19. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (2021-2032) & (Tons)
Figure 22. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Price (2021-2032) & (US$/Ton)
Figure 23. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of Non-steroidal Androgen Receptor Inhibitors?NSARIs? by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer (Revenue) Market Share in 2025
Figure 28. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Region (2021-2032)
Figure 30. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 35. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Type (2021-2032)
Figure 37. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032) & (US$/Ton)
Figure 38. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Application (2021-2032)
Figure 40. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032) & (US$/Ton)
Figure 41. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 53. France Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Region (2021-2032)
Figure 61. China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 64. India Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 81. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
Figure 82. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Restraints
Figure 83. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Non-steroidal Androgen Receptor Inhibitors?NSARIs? in 2025
Figure 86. Manufacturing Process Analysis of Non-steroidal Androgen Receptor Inhibitors?NSARIs?
Figure 87. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
Figure 1. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Picture
Figure 2. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Type in 2025
Figure 4. Enzalutamide Examples
Figure 5. Apalutamide Examples
Figure 6. Darolutamide Examples
Figure 7. Bicalutamide Examples
Figure 8. Nilutamide Examples
Figure 9. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue by Molecular, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Molecular in 2025
Figure 11. High BBB Penetration Examples
Figure 12. Low BBB Penetration Examples
Figure 13. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Application in 2025
Figure 15. nmCRPC Examples
Figure 16. mCRPC Examples
Figure 17. mHSPC Examples
Figure 18. Others Examples
Figure 19. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity (2021-2032) & (Tons)
Figure 22. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Price (2021-2032) & (US$/Ton)
Figure 23. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of Non-steroidal Androgen Receptor Inhibitors?NSARIs? by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturer (Revenue) Market Share in 2025
Figure 28. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Region (2021-2032)
Figure 30. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 35. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Type (2021-2032)
Figure 37. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032) & (US$/Ton)
Figure 38. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Revenue Market Share by Application (2021-2032)
Figure 40. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032) & (US$/Ton)
Figure 41. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 53. France Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Region (2021-2032)
Figure 61. China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 64. India Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Value (2021-2032) & (USD Million)
Figure 81. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
Figure 82. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Restraints
Figure 83. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Non-steroidal Androgen Receptor Inhibitors?NSARIs? in 2025
Figure 86. Manufacturing Process Analysis of Non-steroidal Androgen Receptor Inhibitors?NSARIs?
Figure 87. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
